State Street’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-3,543,911
Closed -$30.1M 3713
2013
Q3
$30.1M Sell
3,543,911
-1,806,701
-34% -$11.4M ﹤0.01% 1448
2013
Q2
$22M Buy
+5,350,612
New +$28.8M ﹤0.01% 1569

State Street's ASTX Position: Q4 2013 in Review

State Street sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 3,543,911 shares — an estimated $30.1M sold.

State Street first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $30.1M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • State Street reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • State Street sold 3,543,911 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $30.1M.
  • State Street first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • State Street's ASTEX PHARMACEUTICALS, INC COM position peaked at $30.1M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on State Street's 13F filing for Q4 2013, filed 6 Feb 2014.